nodes	percent_of_prediction	percent_of_DWPC	metapath
Tapentadol—SLC6A4—bipolar disorder	0.776	1	CbGaD
Tapentadol—SLC6A2—locus ceruleus—bipolar disorder	0.0169	0.193	CbGeAlD
Tapentadol—OPRM1—telencephalic ventricle—bipolar disorder	0.0109	0.125	CbGeAlD
Tapentadol—SLC6A2—autonomic nervous system—bipolar disorder	0.00896	0.103	CbGeAlD
Tapentadol—CYP2C19—urine—bipolar disorder	0.00687	0.0787	CbGeAlD
Tapentadol—CYP2C9—urine—bipolar disorder	0.00533	0.0611	CbGeAlD
Tapentadol—SLC6A4—blood plasma—bipolar disorder	0.00433	0.0496	CbGeAlD
Tapentadol—CYP2D6—urine—bipolar disorder	0.004	0.0458	CbGeAlD
Tapentadol—CYP2C19—blood plasma—bipolar disorder	0.00359	0.0411	CbGeAlD
Tapentadol—Phenylephrine—MAOA—bipolar disorder	0.00335	1	CrCbGaD
Tapentadol—CYP2C9—blood plasma—bipolar disorder	0.00278	0.0319	CbGeAlD
Tapentadol—OPRD1—nervous system—bipolar disorder	0.00227	0.026	CbGeAlD
Tapentadol—OPRK1—nervous system—bipolar disorder	0.00218	0.0249	CbGeAlD
Tapentadol—CYP2D6—blood plasma—bipolar disorder	0.00209	0.0239	CbGeAlD
Tapentadol—OPRK1—cerebellum—bipolar disorder	0.00205	0.0235	CbGeAlD
Tapentadol—OPRD1—brain—bipolar disorder	0.00174	0.0199	CbGeAlD
Tapentadol—HTR3A—nervous system—bipolar disorder	0.00169	0.0193	CbGeAlD
Tapentadol—OPRK1—brain—bipolar disorder	0.00166	0.0191	CbGeAlD
Tapentadol—OPRM1—nervous system—bipolar disorder	0.00155	0.0177	CbGeAlD
Tapentadol—HTR3A—brain—bipolar disorder	0.00129	0.0148	CbGeAlD
Tapentadol—SLC6A4—nervous system—bipolar disorder	0.00129	0.0147	CbGeAlD
Tapentadol—OPRM1—brain—bipolar disorder	0.00118	0.0136	CbGeAlD
Tapentadol—SLC6A2—nervous system—bipolar disorder	0.00113	0.013	CbGeAlD
Tapentadol—SLC6A4—brain—bipolar disorder	0.000984	0.0113	CbGeAlD
Tapentadol—SLC6A2—brain—bipolar disorder	0.000867	0.00993	CbGeAlD
Tapentadol—CYP2D6—nervous system—bipolar disorder	0.000621	0.00711	CbGeAlD
Tapentadol—CYP2D6—cerebellum—bipolar disorder	0.000584	0.00669	CbGeAlD
Tapentadol—CYP2D6—brain—bipolar disorder	0.000474	0.00543	CbGeAlD
Tapentadol—OPRM1—GPCR downstream signaling—TACR1—bipolar disorder	9.08e-05	0.00068	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—TAC1—bipolar disorder	9.07e-05	0.000679	CbGpPWpGaD
Tapentadol—CYP2D6—Biological oxidations—MAOA—bipolar disorder	9.06e-05	0.000678	CbGpPWpGaD
Tapentadol—CYP2C9—Biological oxidations—COMT—bipolar disorder	9.04e-05	0.000677	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—NR1D1—bipolar disorder	9.02e-05	0.000676	CbGpPWpGaD
Tapentadol—CYP2D6—Metapathway biotransformation—COMT—bipolar disorder	9e-05	0.000674	CbGpPWpGaD
Tapentadol—CYP2C9—Biological oxidations—MAOA—bipolar disorder	8.98e-05	0.000672	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—DGKH—bipolar disorder	8.94e-05	0.00067	CbGpPWpGaD
Tapentadol—CYP2C9—Metapathway biotransformation—COMT—bipolar disorder	8.92e-05	0.000668	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—HTR2C—bipolar disorder	8.89e-05	0.000666	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—DRD1—bipolar disorder	8.89e-05	0.000666	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—HTR1A—bipolar disorder	8.89e-05	0.000666	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—TRPC3—bipolar disorder	8.87e-05	0.000664	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—TAC1—bipolar disorder	8.76e-05	0.000656	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—NR1D1—bipolar disorder	8.68e-05	0.00065	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—ADCY2—bipolar disorder	8.67e-05	0.000649	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—NCAN—bipolar disorder	8.63e-05	0.000646	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—DRD3—bipolar disorder	8.61e-05	0.000645	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—HTR2C—bipolar disorder	8.59e-05	0.000643	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—DRD1—bipolar disorder	8.59e-05	0.000643	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—DRD2—bipolar disorder	8.58e-05	0.000642	CbGpPWpGaD
Tapentadol—OPRD1—GPCR ligand binding—POMC—bipolar disorder	8.49e-05	0.000636	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—IMPA2—bipolar disorder	8.49e-05	0.000635	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—ADM—bipolar disorder	8.46e-05	0.000633	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—SLC5A3—bipolar disorder	8.46e-05	0.000633	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—DRD4—bipolar disorder	8.36e-05	0.000626	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—DRD3—bipolar disorder	8.32e-05	0.000623	CbGpPWpGaD
Tapentadol—OPRM1—Class A/1 (Rhodopsin-like receptors)—POMC—bipolar disorder	8.26e-05	0.000619	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—TSHB—bipolar disorder	8.25e-05	0.000617	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—PDE4B—bipolar disorder	8.25e-05	0.000617	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—TACR1—bipolar disorder	8.25e-05	0.000617	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—AKR1C4—bipolar disorder	8.21e-05	0.000615	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—DRD5—bipolar disorder	8.18e-05	0.000612	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—HTR1A—bipolar disorder	8.08e-05	0.000605	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—DRD4—bipolar disorder	8.08e-05	0.000605	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—RGS4—bipolar disorder	8.02e-05	0.000601	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—TAC1—bipolar disorder	7.95e-05	0.000595	CbGpPWpGaD
Tapentadol—OPRM1—GPCR ligand binding—HTR2A—bipolar disorder	7.88e-05	0.00059	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—ADCY2—bipolar disorder	7.87e-05	0.000589	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—IMPA2—bipolar disorder	7.81e-05	0.000584	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—HTR2C—bipolar disorder	7.8e-05	0.000584	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—DRD1—bipolar disorder	7.8e-05	0.000584	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—DRD2—bipolar disorder	7.79e-05	0.000583	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—IMPA2—bipolar disorder	7.74e-05	0.000579	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—ADCY2—bipolar disorder	7.6e-05	0.000569	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—DGKH—bipolar disorder	7.56e-05	0.000566	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—DRD3—bipolar disorder	7.55e-05	0.000566	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—DRD2—bipolar disorder	7.52e-05	0.000563	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—CLOCK—bipolar disorder	7.52e-05	0.000563	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—HTR1A—bipolar disorder	7.52e-05	0.000563	CbGpPWpGaD
Tapentadol—OPRK1—GPCR ligand binding—POMC—bipolar disorder	7.45e-05	0.000557	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—TAC1—bipolar disorder	7.4e-05	0.000554	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—DRD4—bipolar disorder	7.33e-05	0.000549	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—TPH2—bipolar disorder	7.33e-05	0.000549	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—TSHB—bipolar disorder	7.33e-05	0.000549	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—CACNB2—bipolar disorder	7.33e-05	0.000549	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—HTR2C—bipolar disorder	7.26e-05	0.000543	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—DRD1—bipolar disorder	7.26e-05	0.000543	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—DPYD—bipolar disorder	7.21e-05	0.00054	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—TRPC3—bipolar disorder	7.07e-05	0.000529	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—DRD3—bipolar disorder	7.03e-05	0.000526	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—DRD5—bipolar disorder	6.91e-05	0.000518	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—ADCY2—bipolar disorder	6.9e-05	0.000517	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—DRD2—bipolar disorder	6.83e-05	0.000511	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—HTR1A—bipolar disorder	6.83e-05	0.000511	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—DRD4—bipolar disorder	6.82e-05	0.000511	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—RGS4—bipolar disorder	6.78e-05	0.000508	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—ADM—bipolar disorder	6.74e-05	0.000505	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—TAC1—bipolar disorder	6.72e-05	0.000503	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—CACNA1C—bipolar disorder	6.71e-05	0.000502	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—DRD1—bipolar disorder	6.59e-05	0.000494	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—HTR2C—bipolar disorder	6.59e-05	0.000494	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—TSHB—bipolar disorder	6.57e-05	0.000492	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—TACR1—bipolar disorder	6.57e-05	0.000492	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—PDE4B—bipolar disorder	6.57e-05	0.000492	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—PIK3C2A—bipolar disorder	6.53e-05	0.000489	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—CLOCK—bipolar disorder	6.45e-05	0.000483	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—ADCY2—bipolar disorder	6.42e-05	0.000481	CbGpPWpGaD
Tapentadol—CYP2C19—Biological oxidations—POMC—bipolar disorder	6.41e-05	0.00048	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—DRD3—bipolar disorder	6.38e-05	0.000478	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—DRD2—bipolar disorder	6.36e-05	0.000476	CbGpPWpGaD
Tapentadol—OPRM1—GPCR ligand binding—POMC—bipolar disorder	6.29e-05	0.000471	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—TRPC3—bipolar disorder	6.2e-05	0.000464	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—DRD4—bipolar disorder	6.2e-05	0.000464	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—CLOCK—bipolar disorder	6.11e-05	0.000458	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—HTR2A—bipolar disorder	6.01e-05	0.00045	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—TSHB—bipolar disorder	5.96e-05	0.000446	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—TPH2—bipolar disorder	5.96e-05	0.000446	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—CACNB2—bipolar disorder	5.96e-05	0.000446	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—ADM—bipolar disorder	5.91e-05	0.000443	CbGpPWpGaD
Tapentadol—CYP2D6—Biological oxidations—POMC—bipolar disorder	5.9e-05	0.000442	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—CLOCK—bipolar disorder	5.88e-05	0.00044	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—SNAP25—bipolar disorder	5.86e-05	0.000439	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—DPYD—bipolar disorder	5.86e-05	0.000439	CbGpPWpGaD
Tapentadol—CYP2C9—Biological oxidations—POMC—bipolar disorder	5.85e-05	0.000438	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—ADCY2—bipolar disorder	5.83e-05	0.000437	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—DRD2—bipolar disorder	5.77e-05	0.000432	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—TSHB—bipolar disorder	5.76e-05	0.000432	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—PDE4B—bipolar disorder	5.76e-05	0.000432	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—TACR1—bipolar disorder	5.76e-05	0.000432	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—IMPA1—bipolar disorder	5.73e-05	0.000429	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3C2A—bipolar disorder	5.6e-05	0.00042	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—HTR2A—bipolar disorder	5.46e-05	0.000409	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—CACNA1C—bipolar disorder	5.45e-05	0.000408	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—HTR1A—bipolar disorder	5.44e-05	0.000407	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—TAC1—bipolar disorder	5.36e-05	0.000401	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—PIK3C2A—bipolar disorder	5.31e-05	0.000398	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—IMPA1—bipolar disorder	5.27e-05	0.000395	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—HTR2A—bipolar disorder	5.27e-05	0.000394	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—DRD1—bipolar disorder	5.25e-05	0.000393	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—HTR2C—bipolar disorder	5.25e-05	0.000393	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—TRPC3—bipolar disorder	5.24e-05	0.000392	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	5.24e-05	0.000392	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—IMPA1—bipolar disorder	5.23e-05	0.000391	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—ADCY2—bipolar disorder	5.19e-05	0.000388	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—NTRK2—bipolar disorder	5.11e-05	0.000383	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3C2A—bipolar disorder	5.11e-05	0.000383	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—DRD3—bipolar disorder	5.09e-05	0.000381	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—GSK3A—bipolar disorder	5.07e-05	0.000379	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—ADM—bipolar disorder	5e-05	0.000374	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—DRD4—bipolar disorder	4.94e-05	0.00037	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—NDUFV2—bipolar disorder	4.87e-05	0.000365	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—TSHB—bipolar disorder	4.87e-05	0.000365	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—PDE4B—bipolar disorder	4.87e-05	0.000365	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—TACR1—bipolar disorder	4.87e-05	0.000365	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—POMC—bipolar disorder	4.8e-05	0.000359	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—HTR2A—bipolar disorder	4.78e-05	0.000358	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—HTR1A—bipolar disorder	4.77e-05	0.000357	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—SNAP25—bipolar disorder	4.76e-05	0.000357	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—AKR1C4—bipolar disorder	4.72e-05	0.000353	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—TAC1—bipolar disorder	4.7e-05	0.000352	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—ADCY2—bipolar disorder	4.65e-05	0.000348	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—TCF7L2—bipolar disorder	4.63e-05	0.000347	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—DRD1—bipolar disorder	4.61e-05	0.000345	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—HTR2C—bipolar disorder	4.61e-05	0.000345	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—DRD2—bipolar disorder	4.6e-05	0.000345	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—NDUFV2—bipolar disorder	4.48e-05	0.000336	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—NTRK2—bipolar disorder	4.48e-05	0.000336	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—DRD3—bipolar disorder	4.46e-05	0.000334	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—HTR2A—bipolar disorder	4.45e-05	0.000333	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—NDUFV2—bipolar disorder	4.44e-05	0.000333	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—GSK3A—bipolar disorder	4.44e-05	0.000333	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—COMT—bipolar disorder	4.44e-05	0.000333	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—MAOA—bipolar disorder	4.41e-05	0.00033	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—POMC—bipolar disorder	4.36e-05	0.000326	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—AKR1C4—bipolar disorder	4.34e-05	0.000325	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—DRD4—bipolar disorder	4.33e-05	0.000324	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—AKR1C4—bipolar disorder	4.3e-05	0.000322	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—NR1D1—bipolar disorder	4.24e-05	0.000318	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—ADCY2—bipolar disorder	4.21e-05	0.000316	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—POMC—bipolar disorder	4.21e-05	0.000315	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—NTRK1—bipolar disorder	4.17e-05	0.000312	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—ADCY2—bipolar disorder	4.08e-05	0.000305	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—TCF7L2—bipolar disorder	4.06e-05	0.000304	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—NCAN—bipolar disorder	4.06e-05	0.000304	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—S100B—bipolar disorder	4.05e-05	0.000303	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—HTR2A—bipolar disorder	4.04e-05	0.000303	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—DRD2—bipolar disorder	4.04e-05	0.000302	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—HTR1A—bipolar disorder	4.03e-05	0.000302	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—SLC5A3—bipolar disorder	3.97e-05	0.000298	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—TAC1—bipolar disorder	3.97e-05	0.000297	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—NR1D1—bipolar disorder	3.9e-05	0.000292	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—DRD1—bipolar disorder	3.89e-05	0.000292	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—HTR2C—bipolar disorder	3.89e-05	0.000292	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—NR1D1—bipolar disorder	3.87e-05	0.00029	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—POMC—bipolar disorder	3.82e-05	0.000286	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—NTRK2—bipolar disorder	3.79e-05	0.000284	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—DRD3—bipolar disorder	3.77e-05	0.000282	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—GSK3A—bipolar disorder	3.75e-05	0.000281	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—NCAN—bipolar disorder	3.73e-05	0.000279	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—NCAN—bipolar disorder	3.7e-05	0.000277	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—DRD4—bipolar disorder	3.66e-05	0.000274	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—SLC5A3—bipolar disorder	3.66e-05	0.000274	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—NTRK1—bipolar disorder	3.65e-05	0.000274	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—SLC5A3—bipolar disorder	3.62e-05	0.000271	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—COMT—bipolar disorder	3.61e-05	0.00027	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—MTHFR—bipolar disorder	3.59e-05	0.000269	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—MAOA—bipolar disorder	3.58e-05	0.000268	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—NRG1—bipolar disorder	3.57e-05	0.000268	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—POMC—bipolar disorder	3.56e-05	0.000266	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—S100B—bipolar disorder	3.55e-05	0.000266	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—ADCY2—bipolar disorder	3.45e-05	0.000258	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—TCF7L2—bipolar disorder	3.43e-05	0.000257	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—DRD2—bipolar disorder	3.41e-05	0.000255	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—POMC—bipolar disorder	3.23e-05	0.000242	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—HTR2A—bipolar disorder	3.22e-05	0.000241	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—NRG1—bipolar disorder	3.13e-05	0.000235	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—NTRK1—bipolar disorder	3.09e-05	0.000231	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—S100B—bipolar disorder	3e-05	0.000225	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—MTHFR—bipolar disorder	2.92e-05	0.000218	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—CLOCK—bipolar disorder	2.87e-05	0.000215	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—POMC—bipolar disorder	2.87e-05	0.000215	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—INS—bipolar disorder	2.86e-05	0.000214	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—HTR2A—bipolar disorder	2.83e-05	0.000212	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—TPH2—bipolar disorder	2.8e-05	0.00021	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—TSHB—bipolar disorder	2.8e-05	0.00021	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—CACNB2—bipolar disorder	2.8e-05	0.00021	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—DPYD—bipolar disorder	2.75e-05	0.000206	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—NRG1—bipolar disorder	2.65e-05	0.000198	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—CLOCK—bipolar disorder	2.64e-05	0.000198	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—CLOCK—bipolar disorder	2.62e-05	0.000196	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—GSK3B—bipolar disorder	2.6e-05	0.000194	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—TSHB—bipolar disorder	2.58e-05	0.000193	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—TPH2—bipolar disorder	2.58e-05	0.000193	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—CACNB2—bipolar disorder	2.58e-05	0.000193	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—POMC—bipolar disorder	2.57e-05	0.000193	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—CACNA1C—bipolar disorder	2.56e-05	0.000192	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—INS—bipolar disorder	2.56e-05	0.000192	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—TSHB—bipolar disorder	2.55e-05	0.000191	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—CACNB2—bipolar disorder	2.55e-05	0.000191	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—TPH2—bipolar disorder	2.55e-05	0.000191	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—DPYD—bipolar disorder	2.53e-05	0.00019	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—DPYD—bipolar disorder	2.51e-05	0.000188	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—PIK3C2A—bipolar disorder	2.5e-05	0.000187	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	2.46e-05	0.000184	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—HTR2A—bipolar disorder	2.39e-05	0.000179	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—CACNA1C—bipolar disorder	2.36e-05	0.000176	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—CACNA1C—bipolar disorder	2.33e-05	0.000175	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—POMC—bipolar disorder	2.33e-05	0.000175	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—INS—bipolar disorder	2.32e-05	0.000174	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—PIK3C2A—bipolar disorder	2.3e-05	0.000172	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—GSK3B—bipolar disorder	2.28e-05	0.00017	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—PIK3C2A—bipolar disorder	2.28e-05	0.00017	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—POMC—bipolar disorder	2.26e-05	0.000169	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	2.25e-05	0.000168	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—INS—bipolar disorder	2.24e-05	0.000168	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—SNAP25—bipolar disorder	2.24e-05	0.000168	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—SNAP25—bipolar disorder	2.06e-05	0.000154	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—SNAP25—bipolar disorder	2.04e-05	0.000153	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—ADCY2—bipolar disorder	1.98e-05	0.000148	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—GSK3B—bipolar disorder	1.92e-05	0.000144	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—POMC—bipolar disorder	1.91e-05	0.000143	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—INS—bipolar disorder	1.9e-05	0.000142	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—ADCY2—bipolar disorder	1.82e-05	0.000136	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—ADCY2—bipolar disorder	1.81e-05	0.000135	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—COMT—bipolar disorder	1.7e-05	0.000127	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—MAOA—bipolar disorder	1.68e-05	0.000126	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—COMT—bipolar disorder	1.56e-05	0.000117	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—MAOA—bipolar disorder	1.55e-05	0.000116	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—COMT—bipolar disorder	1.55e-05	0.000116	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—MAOA—bipolar disorder	1.54e-05	0.000115	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—MTHFR—bipolar disorder	1.37e-05	0.000103	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—MTHFR—bipolar disorder	1.26e-05	9.44e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—MTHFR—bipolar disorder	1.25e-05	9.36e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—POMC—bipolar disorder	1.1e-05	8.21e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—INS—bipolar disorder	1.09e-05	8.16e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—POMC—bipolar disorder	1.01e-05	7.55e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—INS—bipolar disorder	1e-05	7.51e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—POMC—bipolar disorder	1e-05	7.49e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—INS—bipolar disorder	9.94e-06	7.44e-05	CbGpPWpGaD
